Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience.

Tan, Min Choon; Tan, Jian Liang; Lee, Wei Jun; Srivathsan, Komandoor; Sorajja, Dan; El Masry, Hicham; Scott, Luis R; Lee, Justin Z

Tan, Min Choon; Tan, Jian Liang; Lee, Wei Jun; Srivathsan, Komandoor; Sorajja, Dan; El Masry, Hicham; Scott, Luis R; Lee, Justin Z.

Afiliação

Tan MC; Department of Cardiovascular Medicine Mayo Clinic Arizona Phoenix Arizona USA.
Tan JL; Department of Internal Medicine New York Medical College at Saint Michael's Medical Center Newark New Jersey USA.
Lee WJ; Department of Cardiovascular Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Srivathsan K; International Medical University Kuala Lumpur Malaysia.
Sorajja D; Department of Cardiovascular Medicine Mayo Clinic Arizona Phoenix Arizona USA.
El Masry H; Department of Cardiovascular Medicine Mayo Clinic Arizona Phoenix Arizona USA.
Scott LR; Department of Cardiovascular Medicine Mayo Clinic Arizona Phoenix Arizona USA.
Lee JZ; Department of Cardiovascular Medicine Mayo Clinic Arizona Phoenix Arizona USA.

J Arrhythm ; 39(5): 784-789, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37799789